Tekla Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-382,237
| Closed | -$2.6M | – | 200 |
|
|
2021
Q2 | $2.6M | Hold |
382,237
| – | – | 0.08% | 146 |
|
|
2021
Q1 | $3.93M | Buy |
+382,237
| New | +$3.93M | 0.14% | 133 |
|
|
2019
Q2 | – | Sell |
-10,127
| Closed | -$63K | – | 205 |
|
|
2019
Q1 | $63K | Hold |
10,127
| – | – | ﹤0.01% | 192 |
|
|
2018
Q4 | $34K | Hold |
10,127
| – | – | ﹤0.01% | 202 |
|
|
2018
Q3 | $66K | Hold |
10,127
| – | – | ﹤0.01% | 210 |
|
|
2018
Q2 | $78K | Hold |
10,127
| – | – | ﹤0.01% | 179 |
|
|
2018
Q1 | $226K | Buy |
+10,127
| New | +$226K | 0.01% | 185 |
|